Schedule 13G ownership disclosure

QUOIN PHARMACEUTICALS LTD

American Depositary Shares, each representing Thirty-five (35) Ordinary Shares, no par value per share · CUSIP: 74907L409

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Aberdeen Group plc

    Shares: 75,000 · Class: 8.94%

  • abrdn Inc.

    Shares: 75,000 · Class: 8.94%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001716774-26-000006
Form type
SCHEDULE 13G
Filer
Aberdeen Group plc
CIK
CIK 1716774
Filed
Jan 28, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub